{"DataElement":{"publicId":"6648994","version":"1","preferredName":"Negation Cellular Therapy Therapeutic Procedure Administered Disease Or Clinical Study Type","preferredDefinition":"A description of the disease or study for which non-cellular therapy was administered.","longName":"6648980v1.0:6648990v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"6648980","version":"1","preferredName":"Negation Cellular Therapy Therapeutic Procedure Administered","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction._Utilization of specific cells, modified or not, for treatment of diseases. Donor lymphocyte infusion is a type of cellular therapy._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._The act of having given something (e.g., a medication or test).","longName":"6648978v1.0:2233610v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"6648978","version":"1","preferredName":"Negation Cellular Therapy Therapeutic Procedure","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.:Utilization of specific cells, modified or not, for treatment of diseases. Donor lymphocyte infusion is a type of cellular therapy.:An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","longName":"C25594:C70601:C49236","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Cellular Therapy","conceptCode":"C70601","definition":"Utilization of specific cells, modified or not, for treatment of diseases. Donor lymphocyte infusion is a type of cellular therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"822D6F19-BF95-7FC7-E053-F662850AE9DF","latestVersionIndicator":"Yes","beginDate":"2019-02-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-02-18","modifiedBy":"ONEDATA","dateModified":"2019-02-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233610","version":"1","preferredName":"Administered","preferredDefinition":"Given.","longName":"C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D864-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"822D6F19-BFA3-7FC7-E053-F662850AE9DF","latestVersionIndicator":"Yes","beginDate":"2019-02-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-02-18","modifiedBy":"KUMMEROA","dateModified":"2019-04-17","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6648990","version":"1","preferredName":"Disease Or Clinical Study Type","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research._Type; a subdivision of a particular kind of thing.","longName":"6648990v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other disease / study","valueDescription":"Disease or Disorder Or Clinical Study Other","ValueMeaning":{"publicId":"6648991","version":"1","preferredName":"Disease or Disorder Or Clinical Study Other","longName":"6648991","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research.: Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Clinical Study","conceptCode":"C15206","definition":"Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"822EB100-5EB5-1D8A-E053-F662850ABACC","latestVersionIndicator":"Yes","beginDate":"2019-02-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-02-18","modifiedBy":"ONEDATA","dateModified":"2019-02-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"822EB100-5ECE-1D8A-E053-F662850ABACC","beginDate":"2019-02-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-02-18","modifiedBy":"ONEDATA","dateModified":"2019-02-18","deletedIndicator":"No"},{"value":"MDS","valueDescription":"Myelodysplastic Syndrome","ValueMeaning":{"publicId":"3946618","version":"1","preferredName":"Myelodysplastic Syndrome","longName":"3946618","preferredDefinition":"A clonal hematopoietic disorder characterized by dysplasia and ineffective hematopoiesis in one or more of the hematopoietic cell lines. The dysplasia may be accompanied by an increase in myeloblasts, but the number is less than 20%, which, according to the WHO guidelines, is the requisite threshold for the diagnosis of acute myeloid leukemia. It may occur de novo or as a result of exposure to alkylating agents and/or radiotherapy. (WHO, 2001)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myelodysplastic Syndrome","conceptCode":"C3247","definition":"A clonal hematopoietic disorder characterized by dysplasia and ineffective hematopoiesis in one or more of the hematopoietic cell lines. The dysplasia may be accompanied by an increase in myeloblasts, but the number is less than 20%, which, according to the WHO guidelines, is the requisite threshold for the diagnosis of acute myeloid leukemia. It may occur de novo or as a result of exposure to alkylating agents and/or radiotherapy. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EA87B0E5-6712-6876-E040-BB89AD437204","latestVersionIndicator":"Yes","beginDate":"2013-11-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-11-06","modifiedBy":"GDEEN","dateModified":"2022-06-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"822EB100-5ED8-1D8A-E053-F662850ABACC","beginDate":"2014-12-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-02-18","modifiedBy":"ONEDATA","dateModified":"2019-02-18","deletedIndicator":"No"},{"value":"Multiple myeloma","valueDescription":"Plasma Cell Myeloma","ValueMeaning":{"publicId":"2559811","version":"1","preferredName":"Plasma Cell Myeloma","longName":"2559811","preferredDefinition":"A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia.  Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiple Myeloma","conceptCode":"C3242","definition":"A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia.  Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B6B0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"822EB100-5EE2-1D8A-E053-F662850ABACC","beginDate":"2014-02-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-02-18","modifiedBy":"ONEDATA","dateModified":"2019-02-18","deletedIndicator":"No"},{"value":"Myelofibrosis","valueDescription":"Myelofibrosis","ValueMeaning":{"publicId":"4264965","version":"1","preferredName":"Myelofibrosis","longName":"4264965","preferredDefinition":"A partial or complete replacement of the bone marrow stroma by fibrous tissue.  It can be a primary bone marrow lesion as part of the chronic myeloproliferative disorders (chronic idiopathic myelofibrosis), a manifestation of acute myeloid leukemia (acute panmyelosis with myelofibrosis), or a secondary phenomenon due to bone marrow involvement by a metastatic tumor (e.g., metastatic breast carcinoma). --2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myelofibrosis","conceptCode":"C3248","definition":"A partial or complete replacement of the bone marrow stroma by fibrous tissue.  It can be a primary bone marrow lesion as part of the chronic myeloproliferative disorders (chronic idiopathic myelofibrosis), a manifestation of acute myeloid leukemia (acute panmyelosis with myelofibrosis), or a secondary phenomenon due to bone marrow involvement by a metastatic tumor (e.g., metastatic breast carcinoma). --2003","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F681E9E5-3B91-E912-E040-BB89AD433874","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"822EB100-5EEC-1D8A-E053-F662850ABACC","beginDate":"2016-03-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-02-18","modifiedBy":"ONEDATA","dateModified":"2019-02-18","deletedIndicator":"No"},{"value":"Sickle cell disease","valueDescription":"Sickle Cell Disease","ValueMeaning":{"publicId":"3301976","version":"1","preferredName":"Sickle Cell Disease","longName":"3301976","preferredDefinition":"A blood disorder characterized by the appearance of sickle-shaped red blood cells and anemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sickle Cell Disease","conceptCode":"C34383","definition":"A blood disorder characterized by the appearance of sickle-shaped red blood cells and anemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B128A231-DFDE-22B8-E040-BB89AD436DCB","latestVersionIndicator":"Yes","beginDate":"2011-11-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-11-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"822EB100-5EF6-1D8A-E053-F662850ABACC","beginDate":"2016-03-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-02-18","modifiedBy":"ONEDATA","dateModified":"2019-02-18","deletedIndicator":"No"},{"value":"BMT CTN 17- 02 Study","valueDescription":"BMT CTN 17- 02 Study","ValueMeaning":{"publicId":"6648993","version":"1","preferredName":"BMT CTN 17- 02 Study","longName":"6648993","preferredDefinition":"1702 - Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"822CB450-4439-75B1-E053-F662850AE7BC","latestVersionIndicator":"Yes","beginDate":"2019-02-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-02-18","modifiedBy":"ONEDATA","dateModified":"2019-02-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"822CB450-4452-75B1-E053-F662850AE7BC","beginDate":"2019-02-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-02-18","modifiedBy":"ONEDATA","dateModified":"2019-02-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435032","version":"1","preferredName":"Property or Attribute","preferredDefinition":"The distinguishing qualities or prominent aspect of a person, object, action, process, or substance.","longName":"C20189","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-8321-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6648989","version":"1","preferredName":"Disease or Disorder Or Clinical Study Type","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.:Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research.:Something distinguishable as an identifiable class based on common qualities.","longName":"C2991:C37998:C15206:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Clinical Study","conceptCode":"C15206","definition":"Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"822EB100-5E89-1D8A-E053-F662850ABACC","latestVersionIndicator":"Yes","beginDate":"2019-02-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-02-18","modifiedBy":"ONEDATA","dateModified":"2019-02-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"822EB100-5E9A-1D8A-E053-F662850ABACC","latestVersionIndicator":"Yes","beginDate":"2019-02-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-02-18","modifiedBy":"KUMMEROA","dateModified":"2019-04-17","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"CRIDInd_noncel_dis_cl_st_typ","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the disease or study","type":"Preferred Question Text","description":"What was the disease or study for which non-cellular therapy was administered?","url":null,"context":"NHLBI"},{"name":"Specify the disease / study for which non-cellular therapy was given","type":"Alternate Question Text","description":"Specify the disease / study for which non-cellular therapy was given","url":null,"context":"NHLBI"},{"name":"Specify the disease / study for which non-cellular therapy was given","type":"Application Standard Question Text","description":"Specify the disease / study for which non-cellular therapy was given","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"822CB450-445C-75B1-E053-F662850AE7BC","latestVersionIndicator":"Yes","beginDate":"2019-02-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-02-18","modifiedBy":"KUMMEROA","dateModified":"2019-04-17","changeDescription":". System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}